Skip to main content
. Author manuscript; available in PMC: 2019 Jun 15.
Published in final edited form as: Clin Cancer Res. 2018 Mar 13;24(12):2740–2748. doi: 10.1158/1078-0432.CCR-17-3796

Figure 4. Genetic landscape of tumors from enrolled patients.

Figure 4

(A) Schematic representation (Oncoplot) of most commonly mutated genes and HPV status in all patients enrolled. Each column represents a patient. Colors depict the type of mutations for each gene. (B) Oncoplot comparison between responders vs. non-responders by RECIST criteria adjusted by histological responses as classified for the pharmakodynamic analysis.